Manchester University, GenXys partner for pharmacogenomics awareness, education
Breakthrough science focuses on customizing medication therapy
Fort Wayne, IN (11/02/2022) — GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, is teaming up with Manchester University in northeast Indiana for pharmacogenomics awareness and education.
Pharmacogenomics is a breakthrough science that uses an individual's genetic markers to customize and optimize their medication therapy.
Together, GenXys and Manchester will help drive global recognition of PGx-informed prescribing decisions and in support of expanding use of PGx. This includes pending legislation in the United States known as the Right Drug Dose Now Act.
The partnership will also enable GenXys' expertise and proprietary algorithms to support expansion of genetically informed medication review capabilities in Manchester's educational and research space.
This partnership will further students' learning about evidence-based precision prescribing options for patients, ultimately leading to better health outcomes and empowering the next generation of clinicians to seamlessly utilize PGx in patient care.
Manchester is a national leader in pharmacogenomics education and research. It has on-campus and online master's degree programs in PGx, offers a dual degree in pharmacy (Pharm.D.) and pharmacogenomics (MS in PGx), as well as a graduate certificate in PGx. Its pharmacogenomics program is based at Manchester University Fort Wayne.
Background for the media
GenXys full press release: https://www.prnewswire.com/news-releases/genxys-partners-with-manchester-university-for-pharmacogenomics-education-301663645.html
David Kisor, Pharm.D., is director of pharmacogenomics at Manchester. dfkisor@manchester.edu https://www.manchester.edu/pharmacy/about-pharmacy/faculty-and-staff-profiles/kisor-david
Background on the Right Drug Dose Now Act
How to pronounce pharmacogenomics: far'm-ko-j-no-miks (in Latin, it means pharma with genomics)
Media Attachments
Manchester is a national leader in pharmacogenomics education and research. It has on-campus and online master’s degree programs in PGx, offers a dual degree in pharmacy (Pharm.D.) and pharmacogenomics (MS in PGx), as well as a graduate certificate in PGx. Its pharmacogenomics program is based at Manchester University Fort Wayne.
Manchester University
Dr. David Kisor dfkisor@manchester.eduShare this Story
Recent News
- Manchester University welcomes new College of Business dean
- Manchester University celebrates the Class of 2026
- Vice President Van Vlerah named President of Notre Dame of Maryland University
- Manchester University offers youth esports summer camps
- Manchester University names Rick Espeset Staff Member of the Year
- MU, CFWC holds groundbreaking for phase one of Manchester Mile
- Manchester University's nutrition program earns full accreditation
- MU Esports to add Mario Kart World to lineup in Fall 2026
- Manchester University adds two new reduced-credit degrees
- Manchester University presents 'A Melodious Mosaic' band concert